Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 258
7
Diseases
24
Unique genes
0.199
Avg. similarity score
Arthrogryposis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Arthrogryposis
Digitotalar dysmorphism
Sheldon-hall syndrome
Distal arthrogryposis
Congenital finger flexion contractures
TPM2-related myopathy
childhood-onset nemaline myopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Arthrogryposis | 5 | 5 | 11 |
| Digitotalar dysmorphism | 5 | 5 | 6 |
| Sheldon-hall syndrome | 5 | 5 | 5 |
| Distal arthrogryposis | 4 | 4 | 16 |
| Congenital finger flexion contractures | 3 | 3 | 1 |
| TPM2-related myopathy | 3 | 3 | 1 |
| childhood-onset nemaline myopathy | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TPM2 | 5 / 7 | Arthrogryposis, Digitotalar dysmorphism, Distal arthrogryposis, Sheldon-hall syndrome and 1 more |
| MYH3 | 4 / 7 | Arthrogryposis, Digitotalar dysmorphism, Distal arthrogryposis, Sheldon-hall syndrome |
| TNNI2 | 4 / 7 | Congenital finger flexion contractures, Digitotalar dysmorphism, Distal arthrogryposis, Sheldon-hall syndrome |
| NALCN | 3 / 7 | Digitotalar dysmorphism, Distal arthrogryposis, Sheldon-hall syndrome |
| TNNT3 | 3 / 7 | Digitotalar dysmorphism, Distal arthrogryposis, Sheldon-hall syndrome |
| ECEL1 | 2 / 7 | Arthrogryposis, Distal arthrogryposis |
| MYBPC1 | 2 / 7 | Digitotalar dysmorphism, Distal arthrogryposis |
| TNNI1 | 2 / 7 | Arthrogryposis, childhood-onset nemaline myopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Striated Muscle Contraction | Reactome | 8 / 36 | 111× | 2.01e-15 | 7.33e-13 ✓ sig. |
| Motor proteins | KEGG | 8 / 194 | 20.6× | 2.36e-9 | 2.39e-7 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 8 / 232 | 17.3× | 9.68e-9 | 8.46e-7 ✓ sig. |
| MET activates STAT3 | Reactome | 1 / 3 | 167× | 5.98e-3 | 4.92e-2 ✓ sig. |
| MECP2 regulates neuronal receptors and channels | Reactome | 1 / 4 | 125× | 7.97e-3 | 5.96e-2 |
| MET activates PTPN11 | Reactome | 1 / 5 | 100× | 9.95e-3 | 6.82e-2 |
| MET interacts with TNS proteins | Reactome | 1 / 5 | 100× | 9.95e-3 | 6.82e-2 |
| Stimuli-sensing channels | Reactome | 2 / 79 | 12.7× | 1.07e-2 | 7.18e-2 |
| MET Receptor Activation | Reactome | 1 / 6 | 83.4× | 1.19e-2 | 7.61e-2 |
| MET activates PI3K/AKT signaling | Reactome | 1 / 6 | 83.4× | 1.19e-2 | 7.61e-2 |
| Cardiac muscle contraction | KEGG | 2 / 87 | 11.5× | 1.29e-2 | 7.95e-2 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | Reactome | 1 / 7 | 71.5× | 1.39e-2 | 8.31e-2 |
| InlB-mediated entry of Listeria monocytogenes into host cell | Reactome | 1 / 7 | 71.5× | 1.39e-2 | 8.31e-2 |
| Sema4D mediated inhibition of cell attachment and migration | Reactome | 1 / 8 | 62.6× | 1.59e-2 | 9.02e-2 |
| Hypertrophic cardiomyopathy | KEGG | 2 / 99 | 10.1× | 1.65e-2 | 9.22e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| skeletal muscle contraction | GO:0003009 | 6 / 32 | 146× | 2.02e-12 | 8.65e-10 ✓ sig. |
| muscle contraction | GO:0006936 | 5 / 85 | 45.8× | 6.86e-8 | 8.85e-6 ✓ sig. |
| regulation of ATP-dependent activity | GO:0043462 | 2 / 2 | 779× | 1.58e-6 | 1.19e-4 ✓ sig. |
| cardiac muscle contraction | GO:0060048 | 3 / 43 | 54.3× | 2.22e-5 | 9.75e-4 ✓ sig. |
| sarcomere organization | GO:0045214 | 3 / 43 | 54.3× | 2.22e-5 | 9.75e-4 ✓ sig. |
| regulation of striated muscle contraction | GO:0006942 | 2 / 8 | 195× | 4.41e-5 | 1.64e-3 ✓ sig. |
| neuronal action potential propagation | GO:0019227 | 2 / 11 | 142× | 8.63e-5 | 2.71e-3 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 5 / 404 | 9.6× | 1.39e-4 | 3.87e-3 ✓ sig. |
| neuromuscular process controlling posture | GO:0050884 | 2 / 15 | 104× | 1.64e-4 | 4.39e-3 ✓ sig. |
| muscle filament sliding | GO:0030049 | 2 / 15 | 104× | 1.64e-4 | 4.39e-3 ✓ sig. |
| actin filament-based movement | GO:0030048 | 2 / 21 | 74.2× | 3.27e-4 | 7.12e-3 ✓ sig. |
| striated muscle contraction | GO:0006941 | 2 / 24 | 64.9× | 4.29e-4 | 8.60e-3 ✓ sig. |
| ATP metabolic process | GO:0046034 | 2 / 36 | 43.3× | 9.70e-4 | 1.47e-2 ✓ sig. |
| neuromuscular junction development, skeletal muscle fiber | GO:0098529 | 1 / 1 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |
| positive regulation of vesicle transport along microtubule | GO:1901610 | 1 / 1 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |